Nutrient dependent changes in endogenous NUCB2/nesfatin-1 should also be considered, especially when developing diet or exogenous nesfatin-1 based potential therapies for obesity and related metabolic diseases. This evidence concerns the gene NUCB2 and metabolic disease.